{"pmid":32271125,"title":"Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.","text":["Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.","Metab Syndr Relat Disord","Stoian, Anca Pantea","Banerjee, Yajnavalka","Rizvi, Ali A","Rizzo, Manfredi","32271125"],"journal":"Metab Syndr Relat Disord","authors":["Stoian, Anca Pantea","Banerjee, Yajnavalka","Rizvi, Ali A","Rizzo, Manfredi"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271125","week":"202015|Apr 06 - Apr 12","doi":"10.1089/met.2020.0037","keywords":["COVID-19","cardiovascular disease","endothelial dysfunction","insulin resistance","obesity","type 2 diabetes"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663620083115622400,"score":7.9164424,"similar":[{"pmid":32271993,"title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","text":["High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","Obesity (Silver Spring)","Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce","32271993"],"journal":"Obesity (Silver Spring)","authors":["Simonnet, Arthur","Chetboun, Mikael","Poissy, Julien","Raverdy, Violeta","Noulette, Jerome","Duhamel, Alain","Labreuche, Julien","Mathieu, Daniel","Pattou, Francois","Jourdain, Merce"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271993","week":"202015|Apr 06 - Apr 12","doi":"10.1002/oby.22831","keywords":["COVID-19","SRAS-Cov-2","body mass index","intensive care","mechanical ventilation","obesity"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663620083137642498,"score":65.628334},{"pmid":32259611,"title":"COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used).","text":["COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used).","Diabetes Res Clin Pract","Gentile, Sandro","Strollo, Felice","Ceriello, Antonio","32259611"],"journal":"Diabetes Res Clin Pract","authors":["Gentile, Sandro","Strollo, Felice","Ceriello, Antonio"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259611","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.diabres.2020.108137","keywords":["COVID-19","Diabetes mellitus","Italy","chronically ill patients","comorbidities"],"source":"PubMed","locations":["italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663450393532694528,"score":63.483032},{"pmid":32242993,"title":"Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk.","text":["Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk.","Early data from Wuhan, China show that patients with COVID-19 are typically male, aged 40 to 60 years, and about one-third have comorbidities. Moreover, of 138 COVID-19 patients hospitalized in Wuhan and treated in an intensive care unit (ICU), 25% had cardiovascular disease and 58% hypertension; the respective figures for non-ICU-treated COVID-19 patients were 10% and 22% [1]. Based on these early data, a predisposition to acute cardiac complications related to underlying atherosclerotic cardiovascular disease (ASCVD) may significantly increase the severity of COVID-19 in susceptible individuals.","J Intern Med","Vuorio, Alpo","Watts, Gerald F","Kovanen, Petri T","32242993"],"abstract":["Early data from Wuhan, China show that patients with COVID-19 are typically male, aged 40 to 60 years, and about one-third have comorbidities. Moreover, of 138 COVID-19 patients hospitalized in Wuhan and treated in an intensive care unit (ICU), 25% had cardiovascular disease and 58% hypertension; the respective figures for non-ICU-treated COVID-19 patients were 10% and 22% [1]. Based on these early data, a predisposition to acute cardiac complications related to underlying atherosclerotic cardiovascular disease (ASCVD) may significantly increase the severity of COVID-19 in susceptible individuals."],"journal":"J Intern Med","authors":["Vuorio, Alpo","Watts, Gerald F","Kovanen, Petri T"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242993","week":"202014|Mar 30 - Apr 05","doi":"10.1111/joim.13070","keywords":["COVID-19","PCSK9 inhibitors","atherosclerosis","cardiovascular disease","coronavirus","statins"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135758118912,"score":60.41511},{"pmid":32143502,"title":"Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.","text":["Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.","Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat.","Pathogens","Ashour, Hossam M","Elkhatib, Walid F","Rahman, Md Masudur","Elshabrawy, Hatem A","32143502"],"abstract":["Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat."],"journal":"Pathogens","authors":["Ashour, Hossam M","Elkhatib, Walid F","Rahman, Md Masudur","Elshabrawy, Hatem A"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32143502","week":"202010|Mar 02 - Mar 08","doi":"10.3390/pathogens9030186","keywords":["2019-nCoV","COVID-19","MERS","SARS","SARS-CoV-2"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Treatment","Mechanism"],"weight":1,"_version_":1663352134178963456,"score":51.0974},{"pmid":32209887,"title":"Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment.","text":["Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment.","Chin Med J (Engl)","Lin, John","Ouyang, Jing","Peng, Xiao-Rong","Isnard, Stephane","Fombuena, Brandon","Routy, Jean-Pierre","Chen, Yao-Kai","32209887"],"journal":"Chin Med J (Engl)","authors":["Lin, John","Ouyang, Jing","Peng, Xiao-Rong","Isnard, Stephane","Fombuena, Brandon","Routy, Jean-Pierre","Chen, Yao-Kai"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32209887","week":"202013|Mar 23 - Mar 29","doi":"10.1097/CM9.0000000000000816","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352134928695296,"score":43.44844}]}